{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-048673","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2024-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.130897+00:00","generated_at":"2026-05-29T22:15:49.883297+00:00","sec_items":["1.01","2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BioLife Solutions sells CBS unit to Standex for $6.1M, records $2M in stock comp and $1.5M debt repayment","bullets":["Sold Custom Biogenic Systems (CBS) to Standex International for ~$6.1M; transaction closed Nov 14, 2024.","Incurred $2.0M compensation expense from accelerated share vesting for CBS employees; repaid ~$1.5M of CBS debt.","CBS results classified as discontinued operations; pro forma shows revenue reduction of ~$10.2M for 9mo 2024 and ~$13.6M for FY2023.","Pro forma combined with prior SciSafe sale yields continuing ops net income of $6.9M for 9mo 2024 vs historical net loss $32.6M.","Entered transition services agreement with CBS post-closing; two-year non-compete covenant."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-048673","json":"https://secwatch.observer/filing/0001628280-24-048673.json","markdown":"https://secwatch.observer/filing/0001628280-24-048673.md","text":"https://secwatch.observer/filing/0001628280-24-048673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000162828024048673/0001628280-24-048673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000162828024048673/blfs-20241114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T22:15:49.883297+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}